INQOVI

Taiho Pharmaceutical Co., Ltd.🇺🇸 United States

FDA Page

Effective Date: May 25, 2026
Approval ID: 91a0f80b-f865-4d06-a40d-4d148d99ee71
Products: 1 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INQOVI safely and effectively. See full prescribing information for INQOVI. INQOVI (decitabine and cedazuridine) tablets, for oral useInitial U.S. Approval: 2020

Quick Stats

Total Products1

Labelers2

Label Sections39

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.